These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30662352)

  • 1. COPI-Mediated Nuclear Translocation of EGFRvIII Promotes STAT3 Phosphorylation and PKM2 Nuclear Localization.
    Zhang M; Sun H; Deng Y; Su M; Wei S; Wang P; Yu L; Liu J; Guo J; Wang X; Han X; He Q; Shen L
    Int J Biol Sci; 2019; 15(1):114-126. PubMed ID: 30662352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Mol Cancer Res; 2010 Feb; 8(2):232-45. PubMed ID: 20145033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.
    Fan QW; Cheng CK; Gustafson WC; Charron E; Zipper P; Wong RA; Chen J; Lau J; Knobbe-Thomsen C; Weller M; Jura N; Reifenberger G; Shokat KM; Weiss WA
    Cancer Cell; 2013 Oct; 24(4):438-49. PubMed ID: 24135280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.
    Feng H; Hu B; Vuori K; Sarkaria JN; Furnari FB; Cavenee WK; Cheng SY
    Oncogene; 2014 May; 33(19):2504-12. PubMed ID: 23728337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR and EGFRvIII in glioblastoma: partners in crime.
    Zadeh G; Bhat KP; Aldape K
    Cancer Cell; 2013 Oct; 24(4):403-4. PubMed ID: 24135276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear EGFRvIII resists hypoxic microenvironment induced apoptosis via recruiting ERK1/2 nuclear translocation.
    Xie H; Yang J; Xing W; Dong Y; Ren H
    Biochem Biophys Res Commun; 2016 Feb; 470(2):466-472. PubMed ID: 26742423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
    Chua CY; Liu Y; Granberg KJ; Hu L; Haapasalo H; Annala MJ; Cogdell DE; Verploegen M; Moore LM; Fuller GN; Nykter M; Cavenee WK; Zhang W
    Oncogene; 2016 Feb; 35(6):738-47. PubMed ID: 25893308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
    Learn CA; Hartzell TL; Wikstrand CJ; Archer GE; Rich JN; Friedman AH; Friedman HS; Bigner DD; Sampson JH
    Clin Cancer Res; 2004 May; 10(9):3216-24. PubMed ID: 15131063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking.
    Du Y; Shen J; Hsu JL; Han Z; Hsu MC; Yang CC; Kuo HP; Wang YN; Yamaguchi H; Miller SA; Hung MC
    Oncogene; 2014 Feb; 33(6):756-70. PubMed ID: 23376851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma.
    Rodrigues BR; Queiroz-Hazarbassanov N; Lopes MH; Bleggi-Torres LF; Suzuki S; Cunha IW; Sanematsu P; Martins VR
    Pathol Res Pract; 2016 Jun; 212(6):517-23. PubMed ID: 27013058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem Cells.
    Yin J; Park G; Kim TH; Hong JH; Kim YJ; Jin X; Kang S; Jung JE; Kim JY; Yun H; Lee JE; Kim M; Chung J; Kim H; Nakano I; Gwak HS; Yoo H; Yoo BC; Kim JH; Hur EM; Lee J; Lee SH; Park MJ; Park JB
    PLoS Biol; 2015 May; 13(5):e1002152. PubMed ID: 25992628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin.
    Li B; Yuan M; Kim IA; Chang CM; Bernhard EJ; Shu HK
    Oncogene; 2004 Jun; 23(26):4594-602. PubMed ID: 15077177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.
    Wikstrand CJ; McLendon RE; Friedman AH; Bigner DD
    Cancer Res; 1997 Sep; 57(18):4130-40. PubMed ID: 9307304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to the nucleus and functional association with c-Myc is required for the full oncogenic potential of ΔEGFR/EGFRvIII.
    Gururaj AE; Gibson L; Panchabhai S; Bai M; Manyam G; Lu Y; Latha K; Rojas ML; Hwang Y; Liang S; Bogler O
    J Biol Chem; 2013 Feb; 288(5):3428-38. PubMed ID: 23250739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma.
    An Z; Knobbe-Thomsen CB; Wan X; Fan QW; Reifenberger G; Weiss WA
    Cancer Res; 2018 Dec; 78(24):6785-6794. PubMed ID: 30401716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBPβ promotes angiogenesis through secretion of IL-6, which is inhibited by genistein, in EGFRvIII-positive glioblastoma.
    Liu X; Liu K; Qin J; Hao L; Li X; Liu Y; Zhang X; Liu X; Li P; Han S; Mao Z; Shen L
    Int J Cancer; 2015 Jun; 136(11):2524-34. PubMed ID: 25382637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
    Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
    Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF receptor-mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signaling.
    Chiusa M; Hu W; Zienkiewicz J; Chen X; Zhang MZ; Harris RC; Vanacore RM; Bentz JA; Remuzzi G; Benigni A; Fogo AB; Luo W; Mili S; Wilson MH; Zent R; Hawiger J; Pozzi A
    J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32678881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.
    Liu X; Dong C; Shi J; Ma T; Jin Z; Jia B; Liu Z; Shen L; Wang F
    Oncotarget; 2017 Jan; 8(4):6364-6375. PubMed ID: 28031526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv.
    Kuan CT; Wikstrand CJ; Archer G; Beers R; Pastan I; Zalutsky MR; Bigner DD
    Int J Cancer; 2000 Dec; 88(6):962-9. PubMed ID: 11093822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.